SCHEMBL13638465

SCHEMBL13638465

C=C1CC(Nc2nccc(-c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(N)=O)s3)n2)CC(C)(C)N1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 9/20 0.47
AKT3 Q9Y243 9/20 0.42
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
TEC P42680 1/20 0.36
TXK P42681 1/20 0.36
BTK Q06187 1/20 0.36
ITK Q08881 1/20 0.36
MET P08581 1/20 0.36
KIT P10721 1/20 0.36
PRKCA P17252 1/20 0.36
PRKACA P17612 1/20 0.36
PRKACG P22612 1/20 0.36
PRKACB P22694 1/20 0.36
MAPK3 P27361 1/20 0.36
AKT1 P31749 1/20 0.36
AKT2 P31751 1/20 0.36
CAMK2A Q9UQM7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638565 0.93 AKT3 (0.48) HPGDSAKT3TECTXKBTK
SCHEMBL13638504 0.93 AKT3 (0.48) HPGDSAKT3TECTXKBTK
SCHEMBL13633569 0.89 HPGDS (0.49) HPGDSAKT3CNR1CNR2MET
SCHEMBL13638474 0.86 AKT3 (0.50) AKT3TECTXKBTKITK
SCHEMBL13638466 0.85 AKT3 (0.62) AKT3TECTXKBTKITK
SCHEMBL16192862 0.84 AKT3 (0.47) HPGDSAKT3METKITPRKCA
SCHEMBL16192776 0.84 AKT3 (0.47) HPGDSAKT3METKITPRKCA
SCHEMBL16192777 0.84 AKT3 (0.47) HPGDSAKT3METKITPRKCA
SCHEMBL13638571 0.83 AKT3 (0.40) AKT3TECTXKBTKITK
SCHEMBL13638295 0.82 AKT3 (0.38) AKT3TECTXKBTKITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed